David A. Ricks, SVP and President, Lilly Bio-Meds at LILLY ELI & CO (LLY), sold 16,122 shares at $76.73 ($1.3M) on 2016-02-03, disclosed to the SEC on 2016-02-03.
Open-market sale of $1.3M LLY by SVP and President, Lilly Bio-Meds. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.36 | 3,273 | $256K | 20.4% |
| 2 | $78.36 | 3,273 | $256K | 20.4% |
| 3 | $79.10 | 4,656 | $368K | 29.3% |
| 4 | $76.73 | 2,460 | $189K | 15.0% |
| 5 | $76.73 | 2,460 | $189K | 15.0% |
| Total | $78.08 avg | 16,122 |
| $1.3M |
| 100% |
| Filing → |
| ADBE | BUY | 2025-01-30 | $999K | — | Filing → |
| ADBE | BUY | 2022-09-27 | $337K | — | Filing → |
| LLY | BUY | 2019-10-25 | $1.0M | — | Filing → |